Inventor · disambiguated record
Alberto Bernareggi
Also filed as: BERNAREGGI ALBERTO
12 granted patents·6 pending applications·32 citations·filing 2003–2022
88Inventor score
Files withALTERGON SA5BERNARDINI RAFFAELLA3CEPHALON INC3BERNAREGGI ALBERTO2CELL THERAPEUTICS EUROP S R I1
Top patents by PatentIndex Score
18 records- 0183US8546608B2Proteasome inhibitors and methods of using the sameBERNARDINI RAFFAELLA·Filed 2011·Granted Oct 1, 2013·7 cites·3 claims
- 0283US8058262B2Proteasome inhibitors and methods of using the sameBERNARDINI RAFFAELLA·Filed 2011·Granted Nov 15, 2011·8 cites·82 claims
- 0383US7915236B2Proteasome inhibitors and methods of using the sameCEPHALON INC·Filed 2009·Granted Mar 29, 2011·6 cites·55 claims
- 0478US9233115B2Proteasome inhibitors and methods of using the sameCEPHALON INC·Filed 2013·Granted Jan 12, 2016·3 cites·10 claims
- 0576US7468383B2Proteasome inhibitors and methods of using the sameCEPHALON INC·Filed 2006·Granted Dec 23, 2008·3 cites·22 claims
- 0669US8283367B2Proteasome inhibitors and methods of using the sameBERNARDINI RAFFAELLA·Filed 2008·Granted Oct 9, 2012·1 cites·21 claims
- 0768US10646586B2Aqueous oral solutions of steroid hormones and hydroxypropyl-beta-cyclodextrin with optimised bioavailabilityALTERGON SA·Filed 2013·Granted May 12, 2020·2 cites·14 claims
- 0865US7611733B2Nanoparticle formulations of platinum compoundsCELL THERAPEUTICS EUROPE SRL·Filed 2005·Granted Nov 3, 2009·2 cites·14 claims
- 0959US2025205216A2Piperidine Urea Derivatives for Use as Inotropic AgentsLUND LARS·Filed 2022·Application pending·0 cites
- 1058US2006199831A1Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activityCELL THERAPEUTICS EUROP S R I·Filed 2003·Application pending·0 cites
- 1157US10842883B2Aqueous oral solutions of steroid hormones and hydroxypropyl-β-cyclodextrin with optimised bioavailabilityALTERGON SA·Filed 2020·Granted Nov 24, 2020·0 cites·8 claims
- 1256US2024000791A1Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of TumorsHELSINN HEALTHCARE SA·Filed 2021·Application pending·0 cites
- 1355US9211262B2Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activityBERNAREGGI ALBERTO·Filed 2010·Granted Dec 15, 2015·0 cites·9 claims
- 1454US2016256557A1Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activityCTI BIOPHARMA CORP·Filed 2015·Application pending·0 cites
- 1553US9314435B2Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsulesALTERGON SA·Filed 2012·Granted Apr 19, 2016·0 cites·9 claims
- 1637US2014179785A1Single-dose pharmaceutical preparation of thyroid hormones t3 and/or t4ALTERGON SA·Filed 2012·Application pending·0 cites
- 1733US8426625B2Bis-platinum complexes with antitumor activityBERNAREGGI ALBERTO·Filed 2006·Granted Apr 23, 2013·0 cites·17 claims
- 1832US2016113960A1Topical preparations comprising hyaluronic acid, verbascoside and glycerophosphoinositolALTERGON SA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alberto Bernareggi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →